Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
2.
Nat Genet ; 41(10): 1068-75, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19718027

ABSTRACT

Single-layered embryonic skin either stratifies to form epidermis or responds to Wnt signaling (stabilized beta-catenin) to form hair follicles. Postnatally, stem cells continue to differentially use Wnt signaling in long-term tissue homeostasis. We have discovered that embryonic progenitor cells and postnatal hair follicle stem cells coexpress Tcf3 and Tcf4, which can act as transcriptional activators or repressors. Using loss-of-function studies and transcriptional analyses, we uncovered consequences to the absence of Tcf3 and Tcf4 in skin that only partially overlap with those caused by beta-catenin deficiency. We established roles for Tcf3 and Tcf4 in long-term maintenance and wound repair of both epidermis and hair follicles, suggesting that Tcf proteins have both Wnt-dependent and Wnt-independent roles in lineage determination.


Subject(s)
Epithelial Cells/metabolism , Homeostasis , Nerve Tissue Proteins/metabolism , Signal Transduction , Skin/metabolism , TCF Transcription Factors/metabolism , Animals , Basic Helix-Loop-Helix Leucine Zipper Transcription Factors , Cell Differentiation , Cells, Cultured , Embryo, Mammalian/cytology , Embryo, Mammalian/metabolism , Epithelial Cells/cytology , Female , Male , Mice , Mice, Knockout , Mice, Nude , Nerve Tissue Proteins/deficiency , Nerve Tissue Proteins/genetics , Stem Cells/cytology , Stem Cells/metabolism , TCF Transcription Factors/deficiency , TCF Transcription Factors/genetics , Transcription Factor 4 , Transcription Factor 7-Like 1 Protein , Wnt Proteins/metabolism , Wound Healing , beta Catenin/deficiency , beta Catenin/metabolism
3.
Proc Natl Acad Sci U S A ; 106(15): 6309-14, 2009 Apr 14.
Article in English | MEDLINE | ID: mdl-19251639

ABSTRACT

Notch and Wnt signals play essential roles in intestinal development and homeostasis, yet how they integrate their action to affect intestinal morphogenesis is not understood. We examined the interplay between these two signaling pathways in vivo, by modulating Notch activity in mice carrying either a loss- or a gain-of-function mutation of Wnt signaling. We find that the dramatic proliferative effect that Notch signals have on early intestinal precursors requires normal Wnt signaling, whereas its influence on intestinal differentiation appears independent of Wnt. Analogous experiments in Drosophila demonstrate that the synergistic effects of Notch and Wnt are valid across species. We also demonstrate a striking synergy between Notch and Wnt signals that results in inducing the formation of intestinal adenomas, particularly in the colon, a region rarely affected in available mouse tumor models, but the primary target organ in human patients. These studies thus reveal a previously unknown oncogenic potential of Notch signaling in colorectal tumorigenesis that, significantly, is supported by the analysis of human tumors. Importantly, our experimental evidence raises the possibility that Notch activation might be an essential initial event triggering colorectal cancer.


Subject(s)
Cell Transformation, Neoplastic/metabolism , Cell Transformation, Neoplastic/pathology , Intestinal Neoplasms/metabolism , Intestinal Neoplasms/pathology , Receptors, Notch/metabolism , Signal Transduction , Wnt Proteins/metabolism , Adenoma/genetics , Adenoma/metabolism , Adenoma/pathology , Animals , Basic Helix-Loop-Helix Leucine Zipper Transcription Factors , Cell Differentiation , Cell Proliferation , Cell Transformation, Neoplastic/genetics , Drosophila Proteins/genetics , Drosophila Proteins/metabolism , Drosophila melanogaster , Humans , Intestinal Neoplasms/genetics , Mice , Mice, Inbred C57BL , Mice, Knockout , Nerve Tissue Proteins/deficiency , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Receptors, Notch/genetics , Survival Rate , TCF Transcription Factors/deficiency , TCF Transcription Factors/genetics , TCF Transcription Factors/metabolism , Transcription Factor 4 , Wnt1 Protein/genetics , Wnt1 Protein/metabolism
4.
J Immunol ; 181(9): 5885-94, 2008 Nov 01.
Article in English | MEDLINE | ID: mdl-18941177

ABSTRACT

Little is known about the transcriptional regulators that control the proliferation of multipotent bone marrow progenitors. Understanding the mechanisms that restrict proliferation is of significant interest since the loss of cell cycle integrity can be associated with hematopoietic exhaustion, bone marrow failure, or even oncogenic transformation. Herein, we show that multipotent LSKs (lineage(-)Sca(high)c-kit(+)) from E47-deficient mice exhibit a striking hyperproliferation associated with a loss of cell cycle quiescence and increased susceptibility to in vivo challenge with a mitotoxic drug. Total LSKs contain long-term self-renewing hematopoietic stem cells and downstream multipotential progenitors (MPPs) that possess very limited or no self-renewal ability. Within total LSKs, we found specific developmental and functional deficits in the MPP subset. E47 knockout mice have grossly normal numbers of self-renewing hematopoietic stem cells but a 50-70% reduction in nonrenewing MPPs and downstream lineage-restricted populations. The residual MPPs in E47 knockout mice fail to fully up-regulate flk2 or initiate V(D)J recombination, hallmarks of normal lymphoid lineage progression. Consistent with the loss of normal cell cycle restraints, we show that E47-deficient LSKs have a 50% decrease in p21, a cell cycle inhibitor and known regulator of LSK proliferation. Moreover, enforced expression studies identify p21 as an E47 target gene in primary bone marrow LSKs. Thus, E47 appears to regulate the developmental and functional integrity of early hematopoietic subsets in part through effects on p21-mediated cell cycle quiescence.


Subject(s)
Cell Cycle/immunology , Cell Differentiation/immunology , Hematopoietic Stem Cells/metabolism , Multipotent Stem Cells/metabolism , Resting Phase, Cell Cycle/immunology , TCF Transcription Factors/physiology , Animals , Cell Cycle/genetics , Cell Differentiation/genetics , Cell Line , Cell Lineage/genetics , Cell Lineage/immunology , Cyclin-Dependent Kinase Inhibitor p21/physiology , Gene Targeting , Hematopoietic Stem Cells/cytology , Hematopoietic Stem Cells/immunology , Humans , Mice , Mice, Knockout , Mice, Transgenic , Multipotent Stem Cells/cytology , Multipotent Stem Cells/immunology , Resting Phase, Cell Cycle/genetics , TCF Transcription Factors/biosynthesis , TCF Transcription Factors/deficiency , TCF Transcription Factors/genetics , Transcription Factor 7-Like 1 Protein , Transduction, Genetic
5.
J Immunol ; 177(10): 6723-9, 2006 Nov 15.
Article in English | MEDLINE | ID: mdl-17082585

ABSTRACT

The E-proteins E2A, HeLa E-box binding protein, and E2-2 constitute a class of basic helix-loop-helix transcription factors that differentially affect B cell development. E2A is by far the most investigated and appears to operate at several levels during B cell ontogeny. Less is known concerning the role of the other E-proteins. To address the role of E2-2, we have performed transfers of fetal liver (FL) cells into irradiated Rag-deficient mice. Although the transfer of E2-2-deficient cells alone can reconstitute all B cell subpopulations, albeit with a moderate reduction in cellularity, E2-2-deficient cells have a disadvantage when transferred together with wild-type cells. Cultivation of E2-2(-/-) day 14.5 FL cells on stromal cells and IL-7 revealed a reduced frequency of responding B cell progenitors despite normal IL-7Ralpha surface expression. Real-time PCR analysis revealed that E2-2 mRNA expression is high at the pro-B cell stage and drops sharply at the pre-B cell stage, consistent with a role for E2-2 in pro-B cells. In contrast, E2A mRNA was most abundant in pre-B cells. Analysis of the peripheral repertoire revealed that mice reconstituted with E2-2(-/-) FL cells had an increased proportion of marginal zone (MZ) B cells. Interestingly, E2-2 mRNA was elevated approximately 2-fold (p < 0.01) in follicular compared with MZ B cells. Although E2A mRNA showed a similar tendency, the difference was not significant. Collectively, our findings indicate that E2-2 is required for optimal expansion of pro-B cells, and also influences the follicular vs MZ decision.


Subject(s)
B-Lymphocyte Subsets/cytology , Cell Differentiation/immunology , Spleen/cytology , Spleen/immunology , Stem Cells/cytology , TCF Transcription Factors/physiology , Animals , B-Lymphocyte Subsets/immunology , B-Lymphocyte Subsets/metabolism , B-Lymphocyte Subsets/pathology , Cell Differentiation/genetics , Cell Lineage/genetics , Cell Lineage/immunology , Cell Proliferation , Cells, Cultured , Interleukin-7/physiology , Liver/cytology , Liver/embryology , Liver/immunology , Mice , Mice, Inbred C57BL , Mice, Knockout , RNA, Messenger/biosynthesis , Spleen/pathology , Stem Cells/immunology , Stem Cells/metabolism , Stem Cells/pathology , TCF Transcription Factors/biosynthesis , TCF Transcription Factors/deficiency , Transcription Factor 7-Like 2 Protein
6.
Mol Cell Biol ; 26(20): 7479-91, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16894029

ABSTRACT

The dual function of stem cells requires them not only to form new stem cells through self-renewal but also to form lineage-committed cells through differentiation. Embryonic stem cells (ESC), which are derived from the blastocyst inner cell mass, retain properties of self-renewal and the potential for lineage commitment. To balance self-renewal and differentiation, ESC must carefully control the levels of several transcription factors, including Nanog, Sox2, and Oct4. While molecular mechanisms promoting transcription of these genes have been described, mechanisms preventing excessive levels in self-renewing ESC remain unknown. By examining the function of the TCF family of transcription factors in ESC, we have found that Tcf3 is necessary to limit the steady-state levels of Nanog mRNA, protein, and promoter activity in self-renewing ESC. Chromatin immunoprecipitation and promoter reporter assays showed that Tcf3 bound to a promoter regulatory region of the Nanog gene and repressed its transcriptional activity in ESC through a Groucho interaction domain-dependent process. The absence of Tcf3 caused delayed differentiation of ESC in vitro as elevated Nanog levels persisted through 5 days of embryoid body formation. These new data support a model wherein Tcf3-mediated control of Nanog levels allows stem cells to balance the creation of lineage-committed and undifferentiated cells.


Subject(s)
DNA-Binding Proteins/genetics , Homeodomain Proteins/genetics , Stem Cells/cytology , Stem Cells/metabolism , TCF Transcription Factors/metabolism , Transcription, Genetic/genetics , Animals , Base Sequence , Cell Differentiation , Cell Line , Cell Proliferation , Embryo, Mammalian/cytology , Mice , Mice, Knockout , Nanog Homeobox Protein , TCF Transcription Factors/deficiency , TCF Transcription Factors/genetics , Transcription Factor 7-Like 1 Protein
7.
J Immunol ; 177(1): 395-400, 2006 Jul 01.
Article in English | MEDLINE | ID: mdl-16785535

ABSTRACT

Ig hypermutation is limited to a region of approximately 2 kb downstream of the transcription start sites of the Ig loci. The process requires transcription and the presence of Ig enhancer sequences, and is initiated by the activation-induced cytidine deaminase (AID)-mediated deamination of cytidine bases. It remains unknown why AID causes mutations selectively in the Ig genes and not in most other transcribed loci of B cells. In this study, we report that the inactivation of the E2A gene strongly reduces the rate of Ig L chain mutations in the chicken B cell line DT40 without affecting the levels of surface Ig or AID expression. The defect is complemented by the expression of cDNAs corresponding to either of the two E2A splice variants E12 or E47. The results suggest that E2A-encoded proteins enhance Ig hypermutation by recruitment of AID to the Ig loci.


Subject(s)
Avian Proteins/biosynthesis , Avian Proteins/genetics , Somatic Hypermutation, Immunoglobulin , TCF Transcription Factors/biosynthesis , TCF Transcription Factors/genetics , Animals , Avian Proteins/deficiency , Avian Proteins/physiology , Base Sequence , Cell Line , Chickens , Clone Cells , Cytidine Deaminase/biosynthesis , Cytidine Deaminase/genetics , Cytidine Deaminase/metabolism , DNA, Complementary/biosynthesis , Gene Silencing , Genetic Complementation Test , Genetic Markers , Immunoglobulin Light Chains/genetics , Molecular Sequence Data , Receptors, Antigen, B-Cell/deficiency , Receptors, Antigen, B-Cell/genetics , Sequence Analysis, DNA , TCF Transcription Factors/deficiency , TCF Transcription Factors/physiology
8.
J Exp Med ; 203(5): 1329-42, 2006 May 15.
Article in English | MEDLINE | ID: mdl-16682500

ABSTRACT

The helix-loop-helix protein, E47, is essential for both B- and T-lineage development. Here we demonstrate that in vitro E47 and Notch signaling act in concert to promote T cell development from fetal hematopoietic progenitors and to restrain development into the natural killer and myeloid cell lineages. The expression of an ensemble of genes associated with Notch signaling is activated by E47, and additionally, Notch signaling and E47 act in parallel pathways to induce a T lineage-specific program of gene expression. Enforced expression of the intracellular domain of Notch rescues the developmental arrest at the T cell commitment stage in E2A-deficient fetal thymocytes. Finally, we demonstrate that regulation of Hes1 expression by Notch signaling and E47 is strikingly similar to that observed during Drosophila melanogaster sensory development. Based on these observations, we propose that in developing fetal thymocytes E47 acts to induce the expression of an ensemble of genes involved in Notch signaling, and that subsequently E47 acts in parallel with Notch signaling to promote T-lineage maturation.


Subject(s)
Cell Differentiation/physiology , Cell Lineage/physiology , Hematopoietic Stem Cells/physiology , Signal Transduction/physiology , T-Lymphocytes/physiology , Thymus Gland/embryology , Animals , B-Lymphocytes/cytology , B-Lymphocytes/physiology , Basic Helix-Loop-Helix Transcription Factors/biosynthesis , Drosophila melanogaster , Fetus/cytology , Fetus/embryology , Gene Expression Regulation, Developmental/physiology , Hematopoietic Stem Cells/cytology , Homeodomain Proteins/biosynthesis , Killer Cells, Natural/cytology , Killer Cells, Natural/physiology , Lymphopoiesis/physiology , Mice , Mice, Knockout , Receptors, Notch/metabolism , T-Lymphocytes/cytology , TCF Transcription Factors/deficiency , TCF Transcription Factors/metabolism , Thymus Gland/cytology , Transcription Factor 7-Like 1 Protein , Transcription Factor HES-1
9.
Oncogene ; 25(32): 4441-8, 2006 Jul 27.
Article in English | MEDLINE | ID: mdl-16547505

ABSTRACT

TCF-4 is the main effector of the Wnt/Wingless signalling pathway. As with other TCF/LEF factors, numerous alternative splicings at its 3' end affect its expression. Such a mechanism leads to the synthesis of numerous TCF-4 isoforms among which some contain binding domains for CtBP, an ubiquitous transcriptional corepressor. Of interest, we described a frequent TCF-4 frameshift mutation in mismatch-repair deficient colorectal cancers (MSI-H cancers) that leads to the selective loss of TCF-4 isoforms with CtBP binding abilities. We provide here data that argue for a partial colocalization of CtBP with TCF-4 isoforms containing CtBP binding domains in cellulo, and for a functional role of CtBP in repressing TCF-4 mediated transcription. We also demonstrate that such a colocalization is not observed in MSI-H colorectal cancer cells that harbour the TCF-4 frameshift mutation, and that CtBP is not able to repress TCF-4-mediated transcription in this context. Taken together, our results strongly suggest that CtBP would play a role in regulating TCF-4 mediated transcription upon its binding with some TCF-4 isoforms encoded by alternatively spliced mRNA. They also suggest a role for TCF-4 frameshift mutation during MSI-H colorectal tumour progression, by regulating the relative proportion of the different TCF-4 isoforms.


Subject(s)
Alcohol Oxidoreductases/metabolism , Colorectal Neoplasms/genetics , DNA-Binding Proteins/metabolism , Frameshift Mutation , Nuclear Proteins/antagonists & inhibitors , Repressor Proteins/physiology , TCF Transcription Factors/antagonists & inhibitors , Transcription, Genetic/physiology , Alcohol Oxidoreductases/physiology , Alternative Splicing/physiology , Base Pair Mismatch , Cell Line , DNA-Binding Proteins/physiology , Gene Expression Regulation, Neoplastic/genetics , HCT116 Cells , Humans , Nuclear Proteins/deficiency , Nuclear Proteins/metabolism , Nuclear Proteins/physiology , Protein Isoforms/antagonists & inhibitors , Protein Isoforms/deficiency , Protein Isoforms/metabolism , Protein Isoforms/physiology , Repressor Proteins/genetics , Repressor Proteins/metabolism , TCF Transcription Factors/deficiency , TCF Transcription Factors/metabolism , TCF Transcription Factors/physiology , Transcription Factor 7-Like 2 Protein
10.
Oncogene ; 25(21): 3065-70, 2006 May 18.
Article in English | MEDLINE | ID: mdl-16407833

ABSTRACT

Activation of the Wnt signaling pathway initiates the transformation of colorectal epithelial cells, although the transition to metastatic cancer requires angiogenesis. We have investigated the expression of the von Hippel-Lindau (VHL) tumor suppressor in the intestines from humans and mice. Here, we show that VHL expression is regulated by TCF4 and is restricted to the proliferative compartment at the bottom of intestinal crypts. Accordingly, VHL is completely absent from the proliferative intestinal pockets of Tcf4(-/-) perinatal mice. We observed complementary staining of the hypoxia-inducible factor (HIF) 1alpha to VHL in normal intestinal epithelium as well as in all stages of colorectal cancer (CRC). To the best of our knowledge, this is the first report demonstrating the presence of nuclear HIF1alpha in normoxic healthy adult tissue. Although we observed upregulated levels of VHL in very early CRC lesions from sporadic and familial adenomatous polyposis patients - presumably due to activated Wnt signaling - a clear reduction of VHL expression is observed in later stages of CRC progression, coinciding with stabilization of HIF1alpha. As loss of VHL in later stages of CRC progression results in stabilization of HIF, these data provide evidence that selection for VHL downregulation provides a proangiogenic impulse for CRC progression.


Subject(s)
Adenocarcinoma/etiology , Cell Transformation, Neoplastic/genetics , Colorectal Neoplasms/etiology , Hypoxia-Inducible Factor 1, alpha Subunit/physiology , Nerve Tissue Proteins/physiology , TCF Transcription Factors/physiology , Von Hippel-Lindau Tumor Suppressor Protein/physiology , Wnt Proteins/physiology , beta Catenin/physiology , Adenocarcinoma/genetics , Adenocarcinoma/metabolism , Adenocarcinoma/pathology , Adenoma/genetics , Adenoma/metabolism , Adenoma/pathology , Adenomatous Polyposis Coli/genetics , Adenomatous Polyposis Coli/metabolism , Adenomatous Polyposis Coli/pathology , Animals , Basic Helix-Loop-Helix Leucine Zipper Transcription Factors , Cell Line , Colon/cytology , Colon/metabolism , Colon/pathology , Colonic Polyps/genetics , Colonic Polyps/metabolism , Colonic Polyps/pathology , Colorectal Neoplasms/genetics , Colorectal Neoplasms/metabolism , Colorectal Neoplasms/pathology , Disease Progression , Epithelial Cells/metabolism , Erythropoietin/genetics , Gene Expression Regulation, Neoplastic , Genes, Reporter , Humans , Hypoxia-Inducible Factor 1, alpha Subunit/analysis , Hypoxia-Inducible Factor 1, alpha Subunit/biosynthesis , Intestinal Mucosa/cytology , Intestinal Mucosa/metabolism , Intestinal Mucosa/pathology , Kidney , L Cells , Mice , Mice, Knockout , Neovascularization, Pathologic/genetics , Neovascularization, Pathologic/metabolism , Nerve Tissue Proteins/deficiency , Nerve Tissue Proteins/genetics , Precancerous Conditions/genetics , Precancerous Conditions/metabolism , Precancerous Conditions/pathology , Promoter Regions, Genetic , Recombinant Fusion Proteins/biosynthesis , Recombinant Fusion Proteins/genetics , Signal Transduction/physiology , TCF Transcription Factors/deficiency , TCF Transcription Factors/genetics , Transcription Factor 4
SELECTION OF CITATIONS
SEARCH DETAIL
...